Med Ed Report briefsOrthopedists failed to disclose nearly a third of payments from manufacturers of hip and knee replacements when presenting related research at a recent big meeting, according to a study published in The New England Journal of Medicine. The study gauged the veracity of disclosures by orthopedic surgeons presenting at a 2008 meeting of the American Academy of Orthopaedic Surgeons and found that presenters failed to properly disclose 29% of payments accounting for more than $4 million.
Merck and Schering-Plough spent around $60 million from 2004 to 2008 on CME around cardiovascular topics, according to Dow Jones Newswires. The figures came from the Senate Special Committee on Aging, whose chairman, Sen. Herb Kohl (D-WI), cited them as evidence that “when drug companies fund CME, they see it as money well spent on marketing their latest blockbuster drug.”
Sen. Chuck Grassley (R-IA) wrote NIH acting director Raynard Kingston to prod him to look into ghostwriting by Wyeth and Agency DesignWrite, as alleged in an August New York Times piece. Grassley demanded to know the agency's current policy on ghostwriting with regards to NIH researchers, grantee institutions and primary investigators of NIH grants.